DNA bending and unwinding associated with actinomycin D antibiotics bound to partially overlapping sites on DNA

Journal of Molecular Biology

Volumn 258, Issue 3, 1996, Pages 457-479

  Chen, Huifen ^a   Liu, Xiucai ^a   Patel, Dinshaw J ^a,b  

^a The New York Presbyterian Hospital   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Actinomycin DNA complex; Adjacent overlapping binding sites; DNA bending; Intercalation; Peptide DNA interactions in minor groove

Indexed keywords

ANTIBIOTIC AGENT; CURVED DNA; DACTINOMYCIN; DOUBLE STRANDED DNA;

ARTICLE; BINDING SITE; CHROMATOPHORE; DNA CONFORMATION; DNA DENATURATION; DNA DRUG COMPLEX; DNA HELIX; DNA SEQUENCE; DRUG DNA BINDING; DRUG STRUCTURE; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 0029962943     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0262     Document Type: Article

References (57)

1. Bailly, C., Graves, D. E., Ridge, G. & Waring, M. J. (1994). Use of a photoreactive derivative of actinomycin D to investigate shuffling between binding sites on DNA. Biochemistry, 33, 8376-8745.
2. Bax, A. & Davis, D. G. (1985). MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
3. Brown, D. R., Kurz, M., Kearns, D. R. & Hsu, V. L. (1994). Formation of multiple complexes between actinomycin D and a DNA hairpin: structural characterization by multinuclear NMR. Biochemistry, 33, 651-664.
4. Brown, S. C., Mullis, K., Levenson, C. & Shafer, R. H. (1984). Aqueous solution structure of an intercalated actinomycin D-dATGCAT complex by two-dimensional and one-dimensional proton NMR. Biochemistry, 23, 403-408.
5. Brünger, A. T. (1992). X-PLOR version 3.1. Yale University, CT.
6. Cerami, A., Reich, E., Ward, D. C. & Goldberg, I. H. (1967). The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proc. Natl Acad. Sci. USA, 57, 1036-1042.
7. Chen, F. M. (1992). Binding specificities of actinomycin D to non-self-complementary -XGCY-tetranucleotide sequences. Biochemistry, 31, 6223-6228.
8. Chen, H. & Patel, D. J. (1995). Solution structure of a quinomycin bisintercalator-DNA complex. J. Mol. Biol. 246, 164-179.
9. 2 complex. J. Biomol. Struct. Dynam. 6, 929-969.
10. 31P NMR. J. Biomol. Struct. Dynam. 7, 557-589.
11. Fox, K. R. & Waring, M. J. (1984). DNA structural variations produced by actinomycin and distamycin as revealed by DNase I footprinting. Nucl. Acids Res. 12, 9271-9285.
12. Ginell, S., Lessinger, L. & Berman, H. M. (1988). The crystal and molecular structure of the anticancer drug actinomycin D: some explanations for its unusual properties. Biopolymers, 27, 843-864.
13. Goodisman, J. & Dabrowiak, J. C. (1992). Structural changes and enhancements in DNase I footprinting experiments. Biochemistry, 31, 1058-1064.
14. Goodisman, J., Rehfuss, R., Ward, B. & Dabrowiak, J. C. (1992). Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry, 31, 1046-1058.
15. Jain, S. C. & Sobell, H. M. (1972). Stereochemistry of actinomycin binding to DNA: I. Refinement and further structural details of the actinomycin-deoxyguanosine crystalline complex. J. Mol. Biol. 68, 1-20.
16. Jones, R. L., Scott, E. V., Zon, G., Marzilli, L. G. & Wilson, W. D. (1988). An NMR investigation of the binding of the anticancer drug actinomycin D to oligodeoxyribo-nucleotides with isolated 5′d(GC)3′ binding sites. Biochemistry, 27, 6021-6026.
17. Kamitori, S. & Takusagawa, F. (1992). Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. J. Mol. Biol. 225, 445-456.
18. 2-actinomycin D complexes and its host DNA. J. Am. Chem. Soc. 116, 4154-4165.
19. Kim, Y., Geiger, J. H., Hahn, S. & Sigler, P. B. (1993a). Crystal structure of a yeast TBP/TATA-box complex. Nature, 365, 512-520.
20. Kim, J. L., Nikolov, D. B. & Burley, S. K. (1993b). Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature, 365, 520-527.
21. Koning, T. M. G., Boelens, R. & Kaptein, R. (1990). Calculation of the nuclear Overhauser effect and the determination of proton-proton distances in the presence of internal motions. J. Magn. Reson. 90, 111-123.
22. Krugh, T. R. (1972). Association of actinomycin D and deoxyribonucleotides as a model of binding of the drug to DNA. Proc. Natl Acad. Sci. USA, 69, 1911-1915.
23. Lane, M. J., Dabrowiak, J. C. & Vournakis, J. N. (1983). Sequence specificity of actinomycin D and netropsin binding to pBR322 DNA analyzed by protection from DNase I. Proc. Natl Acad. Sci. USA, 80, 3260-3264.
24. Lavery, R. & Sklenar, H. (1988). The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. J. Biomol. Struct. Dynam. 6, 63-91.
25. Lavery, R. & Sklenar, H. (1989). Defining the structure of irregular nucleic acids: conventions and principles. J. Biomol. Struct. Dynam. 6, 655-667.
26. Liu, X., Chen, H. & Patel, D. J. (1991). Solution structure of actinomycin-DNA complexes: drug intercalation at isolated G-C sites. J. Biomol. NMR, 1, 323-347.
27. Love, J. J., Li, X., Case, D. A., Glese, K., Grosschedl, R. & Wright, P. E. (1995). Structural basis for DNA bending by the architectural transcription factor Lef-1. Nature, 376, 791-795.
28. Meienhofer, J. & Atherton, E. (1977). In Structure-Activity Relationships Amongst the Semisynthetic Antibiotics (Perlman, D., ed.), pp. 427-529, Academic Press, New York.
29. Muller, W. & Crothers, D. M. (1968). Studies of the binding of actinomycin and related compounds to DNA. J. Mol. Biol. 35, 251-290.
30. 1H NMR. Proteins: Struct. Funct. Genet. 17, 297-309.
31. Nilges, M. (1995). Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE cross-peaks and disulfide connectivities. J. Mol. Biol. 245, 645-660.
32. Nilges, M., Habazettl, J., Brünger, A. T. & Holak, T. A. (1991). Relaxation matrix refinement of the solution structure of the squash trypsin inhibitor. J. Mol. Biol. 219, 499-510.
33. Patel, D. J. (1974). Peptide antibiotic-oligonucleotide interactions. Nuclear magnetic resonance investigations of complex formation between actinomycin D and d-ApTpGpCpApT in aqueous solution. Biochemistry, 13, 2396-2402.
34. n duplexes in solution. Helix-coil transition and complex formation with actinomycin D. Biopolymers, 15, 533-558.
35. Patel, D. J. & Canuel, L. (1977). Sequence specificity of mutagen-nucleic acid complexes in solution: intercalation and mutagen-base-pair overlap geometrics for proflavine binding to d(CCGG) and d(GGCC) self-complementary duplexes. Proc. Natl Acad. Sci. USA, 74, 2624-2628.
36. Patel, D. J., Kozlowski, S. A., Rice, J. A., Broka, C. & Itakura, K. (1981). Mutual interaction between adjacent dG·dC actinomycin binding sites and dA·dT netropsin binding sites on the self-complementary d(CGCGAATTCGCG) duplex in solution. Proc. Natl Acad. Sci. USA, 78, 7281-7284.
37. 31P spectra of nucleic acids. J. Am. Chem. Soc. 106, 439-440.
38. Plateau, P. & Gueron, M. (1982). Exchangeable proton NMR without baseline distortion using new strong pulse sequences. J. Am. Chem. Soc. 104, 7310-7311.
39. Reich, E. (1964). Actinomycin D as a probe for nucleic acid secondary structure. Science, 143, 684-689.
40. Reid, D. G., Salisbury, S. A. & Williams, D. H. (1983). Proton nuclear Overhauser effect study of the structure of an actinomycin D complex with a self-complementary tetranucleotide triphosphate. Biochemistry, 22, 1377-1385.
41. Saenger, W. (1984). Principles of Nucleic Acid Structure. Springer-Verlag, New York.
42. Sastry, M., Fiala, R. & Patel, D. J. (1995). Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. J. Mol. Biol. 251, 674-689.
43. 31P NMR investigations of actinomycin D binding specificity with oligodeoxyribonucleotides containing multiple adjacent d(GC) sites. Biochemistry, 27, 915-923.
44. Scott, E. V., Zon, G., Marzilli, L. G. & Wilson, W. D. (1988b). 2D NMR investigation of the binding of the anticancer drug actinomycin D to duplexed dAT-GCGCAT: conformational features of the unique 2:1 adduct. Biochemistry, 27, 7940-7951.
45. 31P NMR coupling constants in double-stranded DNA fragments. J. Am. Chem. Soc. 109, 7525-7526.
46. Sobell, H. M. (1973). The stereochemistry of actinomycin binding to DNA and its implications in molecular biology Prog. Nucl. Acids Res. Mol. Biol. 13, 153-190.
47. Sobell, H. M. & Jain, S. C. (1972). Stereochemistry of actinomycin binding to DNA: II. Detailed molecular model of actinomycin-DNA complex and its implications. J. Mol. Biol. 68, 21-34.
48. Sobell, H. M., Jain, S. C. & Sakore, T. D. (1971). Stereochemistry of actinomycin-DNA binding. Nature New Biol. 231, 200-205.
49. States, D., Haberkorn, R. A. & Ruben, D. J. (1982). A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48, 286-292.
50. Takusagawa, F., Dabrow, M., Neidle, S. & Berman, H. M. (1982). The structure of a pseudo-intercalated complex between actinomycin and the DNA binding sequence d(GpC). Nature, 296, 466-469.
51. van Dyke, M. W., Hertzberg, R. P. & Dervan, P. B. (1982). Map of distamycin, netropsin and actinomycin binding sites on heterogeneous DNA. DNA cleavage-inhibition patterns with methidiumpropyl-EDTA-Fe(II). Proc. Natl Acad. Sci. USA, 79, 5470-5474.
52. Waring, M. J. (1970). Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. J. Mol. Biol. 54, 247-279.
53. Waring, M. J. (1981). DNA modification and cancer. Annu. Rev. Biochem. 50, 159-192.
54. n regions surrounding its GC binding site. J. Biol. Chem. 266, 6381-6388.
55. Wells, R. D. & Larson, J. E. (1970). Studies on the binding of actinomycin D to DNA and DNA model polymers. J. Mol. Biol. 49, 319-342.
56. Werner, M. H., Huth, J. R., Gronenborn, A. M. & Clore, G. M. (1995). Molecular basis of human 46X, Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell, 81, 705-714.
57. 31P NMR evidence for two distinct d(GC) 1:1 adducts and for adjacent site binding in a unique 2:1 adduct. J. Am. Chem. Soc. 108, 7113-7114.